Skip to main content
. 2018 Aug 20;182(6):777–788. doi: 10.1111/bjh.15542

Table 1.

Molecular response in patients with CML: BCR‐ABL1 transcript levels according to the International Scale (Baccarani et al, 2014; Cross et al, 2015)

BCR‐ABL IS, % Log reduction from standardised baseline MR category Minimum number of ABL1 transcripts
100 0
≤0·1 3 MR3 (MMR) >10 000
≤0·01 4 MR4 10 000–31 999
≤0·0032 4·5 MR4·5 32 000–99 999
≤0·001 5 MR5 ≥100 000

CML, chronic myeloid leukaemia; MMR, major molecular response; MR, molecular response.